Nuyten Dimitry SA 4
4 · Arcus Biosciences, Inc. · Filed Aug 24, 2022
Insider Transaction Report
Form 4
Nuyten Dimitry SA
Chief Medical Officer
Transactions
- Award
Common Stock
2022-08-23+42,500→ 42,500 total - Award
Stock Option (Right to Buy)
2022-08-23+170,000→ 170,000 totalExercise: $26.00Exp: 2032-08-22→ Common Stock (170,000 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning September 15, 2023, subject to the Reporting Person's continued service to the Company.
- [F2]The option is exercisable in 48 equal monthly installments after August 1, 2022, subject to the Reporting Person's continued service to the Company.